Mengdie Zhang
Nanjing, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 10 publications
Characteristics of indications, clinical trial evidence, clinical benefits and the costs of price-negotiated multi-indication drugs for solid tumours in China.
Journal: Journal of global health
Published: May 08, 2025
Economic evaluation of camrelizumab plus rivoceranib versus sorafenib as first-line therapy for unresectable hepatocellular carcinoma in the United States and China.
Journal: International journal of clinical pharmacy
Published: April 10, 2024
Availability, price, and affordability of anti-hepatitis B virus drugs: a cross-sectional study in China.
Journal: International journal of clinical pharmacy
Published: December 04, 2023
Evaluating the impact of PD-1 inhibitor treatment on key health outcomes for cancer patients in China.
Journal: International journal of clinical pharmacy
Published: October 04, 2023
Patient versus physician preferences for lipid-lowering drug therapy: A discrete choice experiment.
Journal: Health expectations : an international journal of public participation in health care and health policy
Published: September 15, 2023
The impact of the national volume-based procurement policy on the use of policy-related drugs in Nanjing: an interrupted time-series analysis.
Journal: International journal for equity in health
Published: July 21, 2023
Cost-effectiveness of open pancreaticoduodenectomy with or without Heidelberg TRIANGLE operation for pancreatic cancer in China.
Journal: Journal of cancer research and clinical oncology
Published: July 07, 2023
Cost-effectiveness analysis of CYP2C19 genotype-guided antiplatelet therapy for patients with acute minor ischemic stroke and high-risk transient ischemic attack in China.
Journal: British journal of clinical pharmacology
Published: June 20, 2023
How the National Health Insurance Coverage policy changed the use of lenvatinib for adult patients with advanced hepatocellular carcinoma: a retrospective cohort analysis with real world big data.
Journal: International journal for equity in health
Published: June 16, 2023
Cost-effectiveness analysis of toripalimab plus chemotherapy versus chemotherapy alone for advanced non-small cell lung cancer in China.
Journal: Frontiers in immunology
Published: February 20, 2023
Showing 1-10 of 10
Last Updated: 09/26/2026